A Multiple Dose Pharmacokinetic Study of AMX0035 in Participants with Impaired Hepatic Function and in Healthy Participants

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504397-38-00

Acronym

A35-016

Enrollment

Registered

2023-08-23

Start date

2023-10-31

Completion date

2024-03-20

Last updated

2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers, Volunteers with Hepatic Impairment

None listed

Sex/Gender

All

Age

18 Years to No maximum

Bulgaria

None listed

Source: EU CTIS · Data processed: Feb 4, 2026